Locations:

Tag: septal reduction therapy (SRT)

cardiac MRI showing obstructive hypertrophic cardiomyopathy

November 20, 2024/Heart, Vascular and Thoracic/Clinical Cardiology

Final VALOR-HCM Report: At 128 Weeks, Mavacamten Sustains Gains in HCM Patients

Avoidance of septal reduction therapy continues while LVEF dysfunction remains infrequent

22-HVI-3509429_obstructive-hypertrophic-cardiomyopathy_650x450

January 27, 2023/Heart, Vascular and Thoracic/Clinical Cardiology

Advances in Hypertrophic Cardiomyopathy Therapy: VALOR-HCM May Be Just the Beginning

An abundance of promising studies are on the horizon

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy